TRDA EPS Estimates - Entrada Therapeutics, Inc. logo

TRDA EPS Estimates

Entrada Therapeutics, Inc.

$4.68
-$0.35(-6.96%)
38
Overall
60
Value
20
Tech
34
Quality
How is this score calculated?
Market Cap
$183.22M
Volume
227.49K
52W Range
$4.11 - $16.45
Target Price
$18.75

TRDA EPS estimates: the consensus estimate for Entrada Therapeutics, Inc.'s current fiscal year is -$4.12 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

TRDA EPS Estimates

EPS estimate, current quarter
$-1.25
EPS estimate, next quarter
$-0.97
EPS estimate, current year
$-4.12
EPS estimate, next year
$-3.72
EPS growth, 3-year
-4.74%
TRDA reported EPS by year
Fiscal yearEPS
2025$-3.47
2024$1.76
2023$-0.20
2022$-3.02
2021$-8.16
ABCD
1SymbolPriceChangeVol
2TRDA$4.68-7.0%227.49K
3
4
5
6

Get Entrada Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.